A Functional Variant rs3093023 in CCR6 Is Associated With IgA Nephropathy by Regulating Th17 Cells in a North Han

Yue-Miao Zhang1,2,3, Xing-Zi Liu1,2,3, Xu-Jie Zhou1,2,3

  • 1Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.

Insights

The C-C chemokine receptor 6 (CCR6) gene variant rs3093023 is linked to immunoglobulin A nephropathy (IgAN) susceptibility. This variant influences Th17 cell regulation, potentially impacting disease development.

Area of Science:

  • Immunogenetics
  • Nephrology
  • Molecular Biology

Background:

  • C-C chemokine receptor 6 (CCR6) is implicated in immune-related diseases.
  • CCR6 variants are suggested to play a role in immunoglobulin A nephropathy (IgAN) pathogenesis.
  • Identifying functional variants is crucial for understanding IgAN susceptibility.

Purpose of the Study:

  • To identify functional variants within the CCR6 gene associated with IgAN susceptibility.
  • To elucidate the molecular mechanisms by which CCR6 variants contribute to IgAN.

Main Methods:

  • Genome-wide association study (GWAS) with imputation to analyze CCR6 common and rare variants.
  • Expression quantitative trait loci (eQTL) analysis to assess variant effects on gene expression.
  • Electrophoretic mobility shift assay (EMSA) to investigate protein-DNA binding.
  • Analysis of CCR6 mRNA and protein levels, and correlations with immune cell populations and clinical parameters.

Main Results:

  • Sixty-eight significantly associated common variants in the CCR6 regulatory region were identified.
  • The variant rs3093023 demonstrated a significant association with IgAN susceptibility and an eQTL effect.
  • rs3093023 alleles influenced nuclear protein binding and were associated with increased CCR6+ T cells, diastolic blood pressure, serum creatinine, and tubular atrophy/interstitial fibrosis.

Conclusions:

  • The rs3093023 variant in CCR6 is prioritized as a functional variant contributing to IgAN susceptibility.
  • This variant may exert its effect by regulating Th17 cell differentiation and function.
  • Findings provide insights into the genetic basis of IgAN and potential therapeutic targets.